Keloids are benign cutaneous lesions, arising from proliferating fibroblasts. Keloids of the
ear may occur after helix piercings and are difficult to treat, since they tend to form
recurrences. Guidelines suggest multimodal therapy, however, recurrence rates remain high and
prospective randomized trials are still missing.
To unravel the most effective combination of therapeutic options for keloids of the ear, 20
patients will be enrolled in a prospective, randomized trial. Patients either undergo surgery
using the "fillet technique" and intra-lesional injections of triamcinolone 10mg /ml every 4
to 6 weeks for 6 months, or they are additionally treated with a non-customized pressure
device.